Mesalamine Market Revenue 2024 to 2034
Mesalamine Market Revenue 2024 to 2034
The Mesalamine Market will increase from USD 0.53 Bn in 2024 to USD 0.99 Bn by 2034 at 6.46% CAGR, owing to rising cases of ulcerative colitis, Crohn’s disease, and advancements in GI treatments.
Report ID: 10400
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 0.53 Bn
Forecast Year,
USD 0.99 Bn
CAGR, 2025 -
6.46%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Mesalamine Market Size Analysis
Mesalamine Market Size By Product & Service 2024 to 2034 (USD )
| Product & Service | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | 0.24 | 0.26 | 0.28 | 0.29 | 0.31 | 0.33 | 0.36 | 0.38 | 0.40 | 0.43 | 0.46 |
| Services | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 | 0.26 | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 |
| Software | 0.10 | 0.10 | 0.11 | 0.12 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 |
Mesalamine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical | 0.19 | 0.20 | 0.22 | 0.23 | 0.24 | 0.26 | 0.27 | 0.29 | 0.31 | 0.33 | 0.35 |
| Research | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.22 | 0.23 | 0.25 | 0.27 | 0.28 |
| Operations | 0.13 | 0.14 | 0.14 | 0.15 | 0.16 | 0.17 | 0.19 | 0.20 | 0.21 | 0.22 | 0.24 |
| Others | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.12 |
Mesalamine Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals/Providers | 0.22 | 0.24 | 0.25 | 0.27 | 0.28 | 0.30 | 0.32 | 0.35 | 0.37 | 0.39 | 0.42 |
| Pharma & Biotech | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 | 0.26 |
| Payers/Govt | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.09 | 0.10 | 0.11 | 0.11 | 0.12 |
| Academic/Research | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.15 |
| Others | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
Mesalamine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.20 | 0.21 | 0.23 | 0.24 | 0.26 | 0.28 | 0.29 | 0.31 | 0.33 | 0.35 | 0.38 |
| Europe | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.22 | 0.23 | 0.25 | 0.26 | 0.28 |
| Asia Pacific | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 | 0.26 |
| Latin America | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Middle East & Africa | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
